BCTX
BriaCell Therapeutics Corp. (BCTX)
$00
About BriaCell Therapeutics Corp. (BCTX)
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Details
Daily high
$1.03
Daily low
$0.93
Price at open
$0.93
52 Week High
$5.97
52 Week Low
$0.46
Market cap
33.2M
Dividend yield
0.00%
Volume
312,785
Avg. volume
6.1M
P/E ratio
-.74
BriaCell Therapeutics Corp. News
Details
Daily high
$1.03
Daily low
$0.93
Price at open
$0.93
52 Week High
$5.97
52 Week Low
$0.46
Market cap
33.2M
Dividend yield
0.00%
Volume
312,785
Avg. volume
6.1M
P/E ratio
-.74